The venture capital and investor engagement arm of CPI
A leading deep tech investor
We focus on value-add investments – leveraging our world class technical expertise, facilities and strong partnership network – to stimulate impactful investment into early-stage deep tech businesses.
150+ combined years of experience across our CPI Enterprises team
300+ active investor partnerships
10 deep tech investments including 1 successful exit (14.3x)
800+ SME engagements every year
700+ highly-skilled technology, innovation and industry experts
10 regional offices located across the UK
A hand-picked, highly skilled, and experienced team
The story of CPI Enterprises
Design, engineer and construct bacterial protein polymers containing biological messages that cells need to grow, divide and behave.
Developer of the GRACE, an implanted electrotherapy device for the treatment of brain cancer.
Descycle develop disruptive metal processing techniques to extract precious metals from electronic waste.
BiologIC’s biocomputer platform helps integrate Industry 4.0 technologies to power the biorevolution.
Qkine manufactures high-purity, animal-free growth factors, cytokines and other complex proteins.
Applied Monitoring provide non-invasive trans dermal sensors to address blood science.
Graphene Composites is a developer of graphene based advanced nanomaterials that enhance end-product performance.
We are particularly delighted that CPI, as a world leader in bioprocessing innovation, has joined our high quality investors to further accelerate our commercial and technology traction.
Working with CPI is allowing for a smoother and faster development of our new product, from R&D to commercial development expertise. Our technology empowers engineers to rethink wire harnesses for a safe, sustainable, and reliable all-electric, connected future.